Merck already cut a deal to settle its outstanding Vioxx liability for $4.85 billion, far less than industry observers thought likely.
Now a Texas appeals court has reversed a $32 million verdict that came down against Merck in one of the handful of cases the company litigated before announcing the big settlement deal last year. The [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment